• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PD-1 信号的强度会对 T 细胞效应功能产生不同影响。

Strength of PD-1 signaling differentially affects T-cell effector functions.

机构信息

Department of Microbiology and Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):E2480-9. doi: 10.1073/pnas.1305394110. Epub 2013 Apr 22.

DOI:10.1073/pnas.1305394110
PMID:23610399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3703988/
Abstract

High surface expression of programmed death 1 (PD-1) is associated with T-cell exhaustion; however, the relationship between PD-1 expression and T-cell dysfunction has not been delineated. We developed a model to study PD-1 signaling in primary human T cells to study how PD-1 expression affected T-cell function. By determining the number of T-cell receptor/peptide-MHC complexes needed to initiate a Ca(2+) flux, we found that PD-1 ligation dramatically shifts the dose-response curve, making T cells much less sensitive to T-cell receptor-generated signals. Importantly, other T-cell functions were differentially sensitive to PD-1 expression. We observed that high levels of PD-1 expression were required to inhibit macrophage inflammatory protein 1 beta production, lower levels were required to block cytotoxicity and IFN-γ production, and very low levels of PD-1 expression could inhibit TNF-α and IL-2 production as well as T-cell expansion. These findings provide insight into the role of PD-1 expression in enforcing T-cell exhaustion and the therapeutic potential of PD-1 blockade.

摘要

程序性死亡受体 1(PD-1)的高表面表达与 T 细胞耗竭有关;然而,PD-1 表达与 T 细胞功能障碍之间的关系尚未阐明。我们建立了一个模型来研究原发性人 T 细胞中的 PD-1 信号转导,以研究 PD-1 表达如何影响 T 细胞功能。通过确定启动 Ca(2+)流所需的 T 细胞受体/肽 MHC 复合物的数量,我们发现 PD-1 配体显著改变了剂量反应曲线,使 T 细胞对 T 细胞受体产生的信号的敏感性降低。重要的是,其他 T 细胞功能对 PD-1 表达的敏感性不同。我们观察到,抑制巨噬细胞炎症蛋白 1β的产生需要高水平的 PD-1 表达,阻断细胞毒性和 IFN-γ产生需要较低水平的 PD-1 表达,而非常低水平的 PD-1 表达也可以抑制 TNF-α和 IL-2 的产生以及 T 细胞的扩增。这些发现为 PD-1 表达在强制 T 细胞耗竭中的作用以及 PD-1 阻断的治疗潜力提供了深入的了解。

相似文献

1
Strength of PD-1 signaling differentially affects T-cell effector functions.PD-1 信号的强度会对 T 细胞效应功能产生不同影响。
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):E2480-9. doi: 10.1073/pnas.1305394110. Epub 2013 Apr 22.
2
Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis.程序性死亡(PD)-1:PD-配体1/PD-配体2通路在人类结核病期间抑制T细胞效应功能。
J Immunol. 2008 Jul 1;181(1):116-25. doi: 10.4049/jimmunol.181.1.116.
3
Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens.PD-1 在识别磷酸抗原的人 γδ T 细胞中的表达和功能。
Eur J Immunol. 2011 Feb;41(2):345-55. doi: 10.1002/eji.201040959. Epub 2011 Jan 11.
4
Interferon-γ upregulates Δ42PD1 expression on human monocytes via the PI3K/AKT pathway.干扰素-γ 通过 PI3K/AKT 通路上调人单核细胞上的 Δ42PD1 表达。
Immunobiology. 2019 May;224(3):388-396. doi: 10.1016/j.imbio.2019.02.009. Epub 2019 Feb 21.
5
PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A.PD-1 通过上调 p27 和 p15 并抑制 Cdc25A 来抑制 T 细胞增殖。
Cell Cycle. 2012 Dec 1;11(23):4305-9. doi: 10.4161/cc.22135. Epub 2012 Oct 3.
6
Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.抑制分子调节慢性感染患者 HCV 特异性 CD4+ T 细胞的扩增和恢复。
Gastroenterology. 2011 Oct;141(4):1422-31, 1431.e1-6. doi: 10.1053/j.gastro.2011.07.004. Epub 2011 Jul 18.
7
Immune Checkpoint Receptors Tim-3 and PD-1 Regulate Monocyte and T Lymphocyte Function in Septic Patients.免疫检查点受体 Tim-3 和 PD-1 调节脓毒症患者单核细胞和 T 淋巴细胞功能。
Mediators Inflamm. 2018 Nov 22;2018:1632902. doi: 10.1155/2018/1632902. eCollection 2018.
8
Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.强制表达程序性死亡受体 1 基因可降低 1 型糖尿病的发病率。
Arch Pharm Res. 2010 Nov;33(11):1825-33. doi: 10.1007/s12272-010-1115-3. Epub 2010 Nov 30.
9
Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.T细胞上差异性抑制性受体的表达描绘了慢性病毒感染中的功能能力。
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01263-17. Print 2017 Dec 1.
10
Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface.T细胞长时间暴露于肿瘤坏死因子(TNF)会下调T细胞受体ζ链(TCR zeta)以及细胞表面TCR/CD3复合物的表达。
J Immunol. 2001 May 1;166(9):5495-507. doi: 10.4049/jimmunol.166.9.5495.

引用本文的文献

1
Quantitative analysis of lymphocyte exhaustion markers in patients with localized clear cell renal cell carcinoma.局限性透明细胞肾细胞癌患者淋巴细胞耗竭标志物的定量分析。
Oncol Lett. 2025 Aug 27;30(5):499. doi: 10.3892/ol.2025.15245. eCollection 2025 Nov.
2
Optimal pairing of binder and co-stimulatory domains improves dual CART cell efficacy.结合域与共刺激域的最佳配对可提高双特异性嵌合抗原受体(CART)细胞的疗效。
Mol Ther. 2025 Aug 5. doi: 10.1016/j.ymthe.2025.08.002.
3
Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice.酪氨酸蛋白激酶2的药理学抑制可减轻小鼠胰岛炎症并延缓1型糖尿病的发病。
EBioMedicine. 2025 May 6;117:105734. doi: 10.1016/j.ebiom.2025.105734.
4
Lymphatic chain gradients regulate the magnitude and heterogeneity of T cell responses to vaccination.淋巴链梯度调节T细胞对疫苗接种反应的强度和异质性。
J Exp Med. 2025 Aug 4;222(8). doi: 10.1084/jem.20241311. Epub 2025 Apr 30.
5
A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function.一种检查点逆转受体介导双向激活并增强嵌合抗原受体T细胞功能。
Cancer Res Commun. 2025 Mar 1;5(3):527-548. doi: 10.1158/2767-9764.CRC-24-0125.
6
CAR-T cell therapy for the treatment of adult high-grade gliomas.嵌合抗原受体T细胞疗法用于治疗成人高级别胶质瘤。
NPJ Precis Oncol. 2024 Dec 19;8(1):279. doi: 10.1038/s41698-024-00753-0.
7
PD-1 blockade treatment in melanoma: Mechanism of response and tumor-intrinsic resistance.黑色素瘤中的程序性死亡受体-1阻断治疗:反应机制与肿瘤内在抗性
Cancer Sci. 2025 Feb;116(2):329-337. doi: 10.1111/cas.16398. Epub 2024 Nov 27.
8
Barriers to T Cell Functionality in the Glioblastoma Microenvironment.胶质母细胞瘤微环境中T细胞功能的障碍
Cancers (Basel). 2024 Sep 26;16(19):3273. doi: 10.3390/cancers16193273.
9
Bridging the Gap: Immune Checkpoint Inhibitor as an Option in the Management of Advanced and Recurrent Cervical Cancer in Sub-Saharan Africa.缩小差距:免疫检查点抑制剂作为撒哈拉以南非洲地区晚期和复发性宫颈癌治疗的一种选择
Cureus. 2024 Sep 10;16(9):e69136. doi: 10.7759/cureus.69136. eCollection 2024 Sep.
10
A review of CD4 T cell differentiation and diversity in dogs.犬类CD4 T细胞分化与多样性综述。
Vet Immunol Immunopathol. 2024 Sep;275:110816. doi: 10.1016/j.vetimm.2024.110816. Epub 2024 Aug 21.

本文引用的文献

1
Combination checkpoint blockade--taking melanoma immunotherapy to the next level.联合检查点阻断——将黑色素瘤免疫疗法提升到新高度。
N Engl J Med. 2013 Jul 11;369(2):187-9. doi: 10.1056/NEJMe1305484. Epub 2013 Jun 2.
2
PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A.PD-1 通过上调 p27 和 p15 并抑制 Cdc25A 来抑制 T 细胞增殖。
Cell Cycle. 2012 Dec 1;11(23):4305-9. doi: 10.4161/cc.22135. Epub 2012 Oct 3.
3
Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation.PD-1 对 Akt 和 Ras 通路的选择性作用调节细胞周期的分子成分并抑制 T 细胞增殖。
Sci Signal. 2012 Jun 26;5(230):ra46. doi: 10.1126/scisignal.2002796.
4
PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques.慢性 SIV 感染期间的 PD-1 阻断可减少恒河猴的过度免疫激活和微生物易位。
J Clin Invest. 2012 May;122(5):1712-6. doi: 10.1172/JCI60612. Epub 2012 Apr 23.
5
The blockade of immune checkpoints in cancer immunotherapy.癌症免疫疗法中的免疫检查点阻断。
Nat Rev Cancer. 2012 Mar 22;12(4):252-64. doi: 10.1038/nrc3239.
6
TCR affinity and specificity requirements for human regulatory T-cell function.TCR 亲和力和特异性对人调节性 T 细胞功能的要求。
Blood. 2012 Apr 12;119(15):3420-30. doi: 10.1182/blood-2011-09-377051. Epub 2012 Feb 7.
7
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity.针对 PD-1/B7-H1(PD-L1)通路激活抗肿瘤免疫。
Curr Opin Immunol. 2012 Apr;24(2):207-12. doi: 10.1016/j.coi.2011.12.009. Epub 2012 Jan 9.
8
Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection.PD-L1 和 LAG-3 的治疗性阻断可迅速清除已建立的血期疟原虫感染。
Nat Immunol. 2011 Dec 11;13(2):188-95. doi: 10.1038/ni.2180.
9
PD-L2 is expressed on activated human T cells and regulates their function.PD-L2 在激活的人 T 细胞上表达,并调节其功能。
Mol Immunol. 2011 Sep;48(15-16):2214-9. doi: 10.1016/j.molimm.2011.06.436. Epub 2011 Jul 12.
10
T cell exhaustion.T 细胞耗竭。
Nat Immunol. 2011 Jun;12(6):492-9. doi: 10.1038/ni.2035.